Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue SarcomaMrinal M. Gounder, Albiruni Ryan Abdul Razak, Thaddeus J. Unger et al.|Journal of Clinical Oncology|2016Cited by 165
Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft-Part SarcomaJeremy Lewin, Albiruni R. Abdul Razak, Marcus O. Butler et al.|Cancer Immunology Research|2018Cited by 53
Immunoprofiling in alveolar soft part sarcoma.Samer Salah, Albiruni Ryan Abdul Razak, Jay S. Wunder et al.|Journal of Clinical Oncology|2017Cited by 6